Cargando…

A (relatively) risky business: the link between prostatic radiotherapy and second malignancies

Unlikely to change therapeutic decisions for most men with high grade prostate cancer

Detalles Bibliográficos
Autores principales: Eyler, Christine E, Zietman, Anthony L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775868/
https://www.ncbi.nlm.nih.gov/pubmed/26935234
http://dx.doi.org/10.1136/bmj.i1073
_version_ 1782419072819920896
author Eyler, Christine E
Zietman, Anthony L
author_facet Eyler, Christine E
Zietman, Anthony L
author_sort Eyler, Christine E
collection PubMed
description Unlikely to change therapeutic decisions for most men with high grade prostate cancer
format Online
Article
Text
id pubmed-4775868
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-47758682016-03-10 A (relatively) risky business: the link between prostatic radiotherapy and second malignancies Eyler, Christine E Zietman, Anthony L BMJ Editorials Unlikely to change therapeutic decisions for most men with high grade prostate cancer BMJ Publishing Group Ltd. 2016-03-02 /pmc/articles/PMC4775868/ /pubmed/26935234 http://dx.doi.org/10.1136/bmj.i1073 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.
spellingShingle Editorials
Eyler, Christine E
Zietman, Anthony L
A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title_full A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title_fullStr A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title_full_unstemmed A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title_short A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
title_sort (relatively) risky business: the link between prostatic radiotherapy and second malignancies
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775868/
https://www.ncbi.nlm.nih.gov/pubmed/26935234
http://dx.doi.org/10.1136/bmj.i1073
work_keys_str_mv AT eylerchristinee arelativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies
AT zietmananthonyl arelativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies
AT eylerchristinee relativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies
AT zietmananthonyl relativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies